1-2 of 2
James P. Rizzi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma

Eli M. Wallace, James P. Rizzi, Guangzhou Han, Paul M. Wehn, Zhaodan Cao, Xinlin Du, Tzuling Cheng, Robert M. Czerwinski, Darryl D. Dixon, Barry S. Goggin, Jonas A. Grina, Megan M. Halfmann, Melissa A. Maddie, Sarah R. Olive, Stephen T. Schlachter, Huiling Tan, Bin Wang, Keshi Wang, Shanhai Xie, Rui Xu, Hanbiao Yang, John A. Josey
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (18): 5491–5500.
https://doi.org/10.1158/0008-5472.CAN-16-0473
Published: 15 September 2016
View article titled, A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Open the PDF for A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 551: A potent and selective cFMS inhibitor regulates the tumor macrophage microenvironment leading to tumor growth inhibition

Albion D. Wright, Brandon S. Willis, Anna Gomez, Mark L. Boys, Robert K. DeLisle, Laurence E. Burgess, Mark C. Munson, April L. Kennedy, George T. Topalov, Qian Zhao, Martha E. Rodriguez, Bryson Rast, James P. Rizzi, Walter E. DeWolf, Christine Lemieux, Deborah Anderson, Jason R. Neale, Matthew Martinson, Stefan D. Gross, Michele Callejo, Tyler Risom, Patrice A. Lee
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 551.
https://doi.org/10.1158/1538-7445.AM2011-551
Published: 15 April 2011
View article titled, Abstract 551: A potent and selective cFMS inhibitor regulates the tumor macrophage microenvironment leading to tumor growth inhibition